(19)
(11) EP 4 824 279 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 25707157.1

(22) Date of filing: 17.01.2025
(51) International Patent Classification (IPC): 
C12Q 1/6806(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6806
 
C-Sets:
C12Q 1/6806, C12Q 2563/173, C12Q 2523/301, C12Q 2523/313;
(86) International application number:
PCT/US2025/012120
(87) International publication number:
WO 2025/155871 (24.07.2025 Gazette 2025/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 19.01.2024 IN 202411003901

(71) Applicant: Siemens Healthcare Diagnostics, Inc.
Tarrytown, NY 10591 (US)

(72) Inventors:
  • MITRA, Nivedita
    Bangalore, 560100 (IN)
  • VM, Ramya
    Bangalore,560100 (IN)

(74) Representative: HKW Intellectual Property PartG mbB 
Theresienhöhe 12
80339 München
80339 München (DE)

   


(54) IN-VITRO METHOD FOR SUPPRESSION OF NON-TARGET NUCLEIC ACIDS, KIT AND IMPLEMENTATION THEREOF